Patent US4435408A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4435408A Expired / Lapsed US ⏱️ 0.0 years remaining

Dopaminergic stimulating and antianoxic 4-substituted 2H-indole-2-ones

Assignee: Sanofi Aventis France
•
Filing: 1982-07-15
•
Granted: 1984-03-06
•
Expires: 2002-07-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 2H-indole-2-ones of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms, a and b are both hydrogen or together form a carbon-carbon bond, Z is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms, hydroxyalkyl of 2 to 8 carbon atoms, aryloxyalkyl of 7 to 12 carbon atoms, cycloalkylalkyl of 4 to 12 carbon atoms, alkenyl and alkynyl of 3 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms optionally substituted with at least one member of the group consisting of halogen, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms, --OH, --CF 3 , --OCF 3 , --NO 2 and --NH 2 and their nontoxic, pharmaceutically acceptable acid addition salts having remarkable dopaminergic stimulating and antianoxic properties and their preparation.

Inventors

  • 👤 Lucien Nedelec
  • 👤 Jacques Guillaume
  • 👤 Claude Dumont

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 01:56
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; A; A61; A61P; A61P25/00

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 151 words
A compound selected from the group consisting of 2H-indole-2-ones of the formula ##STR8## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms, a and b are both hydrogen or together form a carbon-carbon bond, Z is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms, hydroxyalkyl of 2 to 8 carbon atoms, aryloxyalkyl of 7 to 12 carbon atoms, cycloalkylalkyl of 4 to 12 carbon atoms, alkenyl and alkynyl of 3 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms optionally substituted with at least one member of the group consisting of halogen, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms, --OH, --CF 3 , --OCF 3 , --NO 2 and --NH 2 and their non-toxic, pharmaceutically acceptable acid addition salts.
Claim 2
Dependent Claim 151 words
A compound selected from the group consisting of 2H-indole-2-ones of the formula ##STR8## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms, a and b are both hydrogen or together form a carbon-carbon bond, Z is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms, hydroxyalkyl of 2 to 8 carbon atoms, aryloxyalkyl of 7 to 12 carbon atoms, cycloalkylalkyl of 4 to 12 carbon atoms, alkenyl and alkynyl of 3 to 8 carbon atoms and aralkyl of 7 to 12 carbon atoms optionally substituted with at least one member of the group consisting of halogen, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms, --OH, --CF 3 , --OCF 3 , --NO 2 and --NH 2 and their non-toxic, pharmaceutically acceptable acid addition salts.
Claim 3
Dependent Claim 23 words
A compound of claim 1 wherein R is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 4
Dependent Claim 25 words
A compound of claim 1 or 2 wherein Z is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 5
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 1,3-dihydro-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 6
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 1,3-dihydro-4-(piperidin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 7
Dependent Claim 26 words
A dopaminergic stimulating and antianoxic composition comprising a dopaminergic stimulating and antianoxically effective amount of at least one compound of claim 1 and a pharmaceutical carrier.
Claim 8
Dependent Claim 26 words
A composition of claim 6 wherein in the compound R is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 9
Dependent Claim 28 words
A composition of claim 6 or 7 wherein in the compound Z is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 10
Dependent Claim 25 words
A composition of claim 6 wherein the active compound is selected from the group consisting of 1,3-dihydro-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 11
Dependent Claim 25 words
A composition of claim 6 wherein the active compound is selected from the group consisting of 1,3-dihydro-4-(piperidin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 12
Dependent Claim 32 words
A method of inducing dopaminergic stimulating and antianoxic activity in warm-blooded animals comprising administering to warm-blooded animals a dopaminergic stimulating and antianoxically effective amount of at least one compound of claim 1.
Claim 13
Dependent Claim 26 words
A method of claim 11 wherein in the compound R is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 14
Dependent Claim 26 words
A method of claim 11 wherein in the compound Z is selected from the group consisting of hydrogen and alkyl of 1 to 8 carbon atoms.
Claim 15
Dependent Claim 25 words
A method of claim 11 wherein the active compound is selected from the group consisting of 1,3-dihydro-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 16
Dependent Claim 25 words
A method of claim 11 wherein the active compound is selected from the group consisting of 1,3-dihydro-4-(piperidin-3-yl)-2H-indole-2-one and its non-toxic, pharmaceutically acceptable acid addition salts.

References Cited (Backward Citations)

US3325499A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-06 1987-09-05 1988-03-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-06 1991-09-05 1992-03-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-06 1995-09-05 1996-03-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag